• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

7
2
2
2

COUNTRY

2
1

CATEGORIES

  • 44
  • 15
  • 9
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

44
44
57
76

PUBLISHED

0
2
10
76

PRODUCT TYPE

70
4
2

Search "Lorus Therapeutics Incorporated" returned 76 results.

PRODUCT TITLE
Lorus Therapeutics Inc (LOR) - Financial and Strategic SWOT Analysis Review Lorus Therapeutics Inc (LOR) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Lorus Therapeutics Inc (LOR) - Financial and Strategic SWOT Analysis Review

Lorus Therapeutics Inc (LOR) - Financial and Strategic SWOT Analysis Review Summary Lorus Therapeutics Inc. (Lorus) is a biopharmaceutical company with focus on the discovery, research and development...

September 2012
FROM

Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review

Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

July 2014
FROM

Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma

“Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma” provides insights into the unmet needs in the pharmaceutical and healthcare market and potential segments where...

February 2010
FROM
Analysis of Genta Incorporated Analysis of Genta Incorporated - Product Thumbnail Image

Analysis of Genta Incorporated

Analysis of Genta Incorporated. A complete and comprehensive analysis of Genta Incorporated, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry,...

April 2013
FROM

Melanoma - Pipeline Review, H2 2013

Melanoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2013

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline...

September 2013
FROM
Gram-Positive Bacterial Infections - Pipeline Review, H1 2013 Gram-Positive Bacterial Infections - Pipeline Review, H1 2013 - Product Thumbnail Image

Gram-Positive Bacterial Infections - Pipeline Review, H1 2013

Gram-Positive Bacterial Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gram-Positive Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM

Staphylococcus Aureus Infections - Pipeline Review, H1 2013

Staphylococcus Aureus Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Staphylococcus Aureus Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

May 2013
FROM
Melanoma - Pipeline Review, H1 2013 Melanoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2013

Melanoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

February 2013
FROM

Colon Cancer - Pipeline Review, H2 2013

Colon Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Colon Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM
Metastatic Melanoma - Pipeline Review, H2 2012 Metastatic Melanoma - Pipeline Review, H2 2012 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Review, H2 2012

Metastatic Melanoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Metastatic Melanoma - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...

September 2012
FROM

Skin Cancer - Pipeline Review, H1 2013

Skin Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Skin Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

May 2013
FROM
Melanoma - Pipeline Review, H2 2012 Melanoma - Pipeline Review, H2 2012 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2012

Melanoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H2 2012', provides an overview of the Melanoma therapeutic pipeline. This report provides information...

August 2012
FROM
Staphylococcus Aureus Infections - Pipeline Review, H2 2012 Staphylococcus Aureus Infections - Pipeline Review, H2 2012 - Product Thumbnail Image

Staphylococcus Aureus Infections - Pipeline Review, H2 2012

Staphylococcus Aureus Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Staphylococcus Aureus Infections - Pipeline Review, H2 2012', provides an overview of the indication’s...

November 2012
FROM
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2013 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2013 - Product Thumbnail Image

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2013

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline...

March 2013
FROM
Metastatic Melanoma - Pipeline Review, H1 2013 Metastatic Melanoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Review, H1 2013

Metastatic Melanoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Melanoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

March 2013
FROM
Streptococcal Infections - Pipeline Review, H1 2013 Streptococcal Infections - Pipeline Review, H1 2013 - Product Thumbnail Image

Streptococcal Infections - Pipeline Review, H1 2013

Streptococcal Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Streptococcal Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Intestinal Cancer - Pipeline Review, H2 2012 Intestinal Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Intestinal Cancer - Pipeline Review, H2 2012

Intestinal Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Intestinal Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...

December 2012
FROM
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2012 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2012 - Product Thumbnail Image

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2012

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline...

September 2012
FROM
Male Cancer - Pipeline Review, H2 2012 Male Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Male Cancer - Pipeline Review, H2 2012

Male Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Male Cancer - Pipeline Review, H2 2012', provides an overview of the Male Cancer therapeutic pipeline. This report provides...

August 2012
FROM
Loading Indicator